222 related articles for article (PubMed ID: 11565082)
21. [Pneumocystosis of splenic localization in the course of HIV infection: a new indication for splenectomy. Description of a case].
Galimberti A; Morandi E; Giani G; Vitri P; Piraneo S; De Pasquale L; Bastagli A
Ann Ital Chir; 1997; 68(4):559-62; discussion 562-3. PubMed ID: 9494189
[TBL] [Abstract][Full Text] [Related]
22. Cytomegalovirus pneumonia in transplant recipients.
Ison MG; Fishman JA
Clin Chest Med; 2005 Dec; 26(4):691-705, viii. PubMed ID: 16263406
[TBL] [Abstract][Full Text] [Related]
23. Pneumocystis carinii pneumonia with pleural effusion in a non-HIV host.
Balasubramanian VP; Komorowski RA; Santo Tomas LH
WMJ; 2006 Jan; 105(1):62-5. PubMed ID: 16676494
[TBL] [Abstract][Full Text] [Related]
24. Toxicity and efficacy of daily dapsone as Pneumocystis jiroveci prophylaxis after hematopoietic stem cell transplantation: a case-control study.
Sangiolo D; Storer B; Nash R; Corey L; Davis C; Flowers M; Hackman RC; Boeckh M
Biol Blood Marrow Transplant; 2005 Jul; 11(7):521-9. PubMed ID: 15983552
[TBL] [Abstract][Full Text] [Related]
25. The prevention of infection post-transplant: the role of prophylaxis, preemptive and empiric therapy.
Marty FM; Rubin RH
Transpl Int; 2006 Jan; 19(1):2-11. PubMed ID: 16359371
[TBL] [Abstract][Full Text] [Related]
26. Dual infection with Pneumocystis carinii and Pasteurella pneumotropica in B cell-deficient mice: diagnosis and therapy.
Macy JD; Weir EC; Compton SR; Shlomchik MJ; Brownstein DG
Comp Med; 2000 Feb; 50(1):49-55. PubMed ID: 10987669
[TBL] [Abstract][Full Text] [Related]
27. Experimental evaluation of roxithromycin combined with dapsone or sulphamethoxazole on Pneumocystis carinii and Toxoplasma gondii dual infections in a rat model.
Brun-Pascaud M; Chau F; Derouin F; Girard PM
J Antimicrob Chemother; 1998 Mar; 41 Suppl B():57-62. PubMed ID: 9579714
[TBL] [Abstract][Full Text] [Related]
28. The impact of novel immunosuppressive agents on infections in organ transplant recipients and the interactions of these agents with antimicrobials.
Husain S; Singh N
Clin Infect Dis; 2002 Jul; 35(1):53-61. PubMed ID: 12060875
[TBL] [Abstract][Full Text] [Related]
29. Infection in renal transplant recipients.
Fishman JA
Semin Nephrol; 2007 Jul; 27(4):445-61. PubMed ID: 17616276
[TBL] [Abstract][Full Text] [Related]
30. [Trimethoprim-sulfamethoxazole as antibacterial prophylaxis during induction therapy of children with acute lymphatic leukemia].
Agger KE; Schrøder H; Rosthøj S; Carlsen NT; Schmiegelow K
Ugeskr Laeger; 2002 Jan; 164(4):488-92. PubMed ID: 11838420
[TBL] [Abstract][Full Text] [Related]
31. Strategies for the prevention of infection after solid organ transplantation.
Hanson K; Alexander B
Expert Rev Anti Infect Ther; 2006 Oct; 4(5):837-52. PubMed ID: 17140359
[TBL] [Abstract][Full Text] [Related]
32. Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection.
Kim YJ; Boeckh M; Englund JA
Semin Respir Crit Care Med; 2007 Apr; 28(2):222-42. PubMed ID: 17458776
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection.
Schürmann D; Bergmann F; Albrecht H; Padberg J; Wünsche T; Grünewald T; Schürmann M; Grobusch M; Vallée M; Ruf B; Suttorp N
Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):353-61. PubMed ID: 12072919
[TBL] [Abstract][Full Text] [Related]
34. Antibacterial prophylaxis with trimethoprim-sulfamethoxazole during induction treatment for acute lymphoblastic leukemia.
Schrøder H; Agger KE; Rosthøj S; Carlsen NT; Schmiegelow K
Dan Med Bull; 2001 Nov; 48(4):275-7. PubMed ID: 11767129
[TBL] [Abstract][Full Text] [Related]
35. Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis Carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ.
Leoung GS; Stanford JF; Giordano MF; Stein A; Torres RA; Giffen CA; Wesley M; Sarracco T; Cooper EC; Dratter V; Smith JJ; Frost KR;
J Infect Dis; 2001 Oct; 184(8):992-7. PubMed ID: 11574913
[TBL] [Abstract][Full Text] [Related]
36. Resistance to trimethoprim-sulfamethoxazole.
Huovinen P
Clin Infect Dis; 2001 Jun; 32(11):1608-14. PubMed ID: 11340533
[TBL] [Abstract][Full Text] [Related]
37. The use of donor and recipient screening for toxoplasma in the era of universal trimethoprim sulfamethoxazole prophylaxis.
Gourishankar S; Doucette K; Fenton J; Purych D; Kowalewska-Grochowska K; Preiksaitis J
Transplantation; 2008 Apr; 85(7):980-5. PubMed ID: 18408578
[TBL] [Abstract][Full Text] [Related]
38. Major complications following hematopoietic stem cell transplantation.
Afessa B; Peters SG
Semin Respir Crit Care Med; 2006 Jun; 27(3):297-309. PubMed ID: 16791762
[TBL] [Abstract][Full Text] [Related]
39. Pneumocystis jirovecii in solid organ transplant recipients: updates in epidemiology, diagnosis, treatment, and prevention.
Saadatzadeh T; Angarone M; Stosor V
Curr Opin Infect Dis; 2024 Apr; 37(2):121-128. PubMed ID: 38230604
[TBL] [Abstract][Full Text] [Related]
40. Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation.
Bacigalupo A; Sormani MP; Lamparelli T; Gualandi F; Occhini D; Bregante S; Raiola AM; di Grazia C; Dominietto A; Tedone E; Piaggio G; Podesta M; Bruno B; Oneto R; Lombardi A; Frassoni F; Rolla D; Rollandi G; Viscoli C; Ferro C; Garbarino L; Van Lint MT
Haematologica; 2004 Oct; 89(10):1238-47. PubMed ID: 15477210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
